Recent Events & Catalysts
ANI Pharmaceuticals, Inc. (ANIP) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
These Analysts Slash Their Forecasts On ANI Pharmaceuticals After Q2 Results
Benzinga · 1d ago
Guggenheim Maintains Buy on ANI Pharmaceuticals, Lowers Price Target to $119
Benzinga · 1d ago
Canaccord Genuity Maintains Hold on ANI Pharmaceuticals, Lowers Price Target to $90
Benzinga · 1d ago
ANI Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation
SeekingAlpha · 3d ago
ANI Pharmaceuticals, Inc. (ANIP) Q2 2026 Earnings Call Transcript
SeekingAlpha · 4d ago
ANI Pharmaceuticals (NASDAQ:ANIP) Tumbles on Weak Guidance Despite Q2 EPS Beat
ChartMill · 4d ago
ANI Pharmaceuticals Affirms FY2026 Adj EPS Guidance of $9.19-$9.69 vs $9.45 Est; Affirms FY2026 Sales Guidance of $1.080B-$1.140B vs $1.119B Est
Benzinga · 4d ago
ANI Pharmaceuticals Q2 Adj. EPS $2.21 Beats $2.05 Estimate, Sales $266.044M Beat $260.128M Estimate
Benzinga · 4d ago
SEC Filings (90 days)
Results of operations (earnings release), Regulation FD disclosure, Financial statements and exhibits
Filed 2026-08-07 · 4d ago · Material
Departure/appointment of directors or officers, Submission of matters to a vote of security holders, Financial statements and exhibits
Filed 2026-05-21 · 82d ago
Regulation FD disclosure, Financial statements and exhibits
Filed 2026-05-13 · 90d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.